Drug Shortage Report for TEVA-NARATRIPTAN

Last updated on 2021-01-21 History
Report ID 128632
Drug Identification Number 02314290
Brand name TEVA-NARATRIPTAN
Common or Proper name Naratriptan Tablets
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) NARATRIPTAN
Strength(s) 1MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size P/PACK 8
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2020-11-18
Estimated end date 2021-01-31
Actual end date 2021-01-20
Shortage status Resolved
Updated date 2021-01-21
Company comments Product is short-dated, new product coming at end of 2020
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2021-01-21 French Compare
v5 2021-01-21 English Compare
v4 2021-01-07 French Compare
v3 2021-01-07 English Compare
v2 2020-11-19 French Compare
v1 2020-11-19 English Compare